27 Results for "

signature

" in MedChemExpress (MCE) Product Catalog:
Products (27)

27 Results for "signature" in MCE Product Catalog:

8
8 Publications Verification
Cat. No.: HY-138280
CAS No.: 897326-30-6
Purity:  99.82%
Target:  

HSP

Research Areas:  

Cancer

DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1. DTHIB has potently anticancer activities and can be used for prostate cancer research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P99459
CAS No.: 909110-25-4
Synonyms: BG 9924; TT-47

Target:  

TNF Receptor CXCR

Research Areas:  

Inflammation/Immunology

Baminercept (BG 9924; TT-47) is an Ig fusion protein targeting the lymphotoxin β receptor (LTβR). Baminercept effectively regulates subsets of circulating immune cells by inhibiting LIGHT, LT-α1β2 and their receptors. Baminercept also increases blood lymphocyte counts and reduces plasma CXCL13 levels. Baminercept carries a high risk of hepatotoxicity. Baminercept can be used in research on rheumatoid arthritis and primary Sjögren's syndrome .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-126855
CAS No.: 60320-05-0
Purity:  99.92%
Synonyms: 7-Sulfocholic acid
Cholic acid 7-sulfate (7-Sulfocholic acid) is a selective agonist targeting TGR5 (EC50=0.17 μM) and a ligand for MHC class I-related protein (MR1). As a gut-restricted TGR5 agonist, cholic acid 7-sulfate binds to TGR5 on enteroendocrine L cells, induces GLP-1 secretion, and improves glucose tolerance in a TGR5-dependent manner. Cholic acid 7-sulfate also acts as an endogenous ligand for MR1, promoting the survival of mucosal-associated invariant T cells MAIT and the expression of homeostatic gene signatures, affecting MAIT cell development and function. Cholic acid 7-sulfate is mainly used in the research of diabetes and MAIT cell-related immune regulation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-123820
CAS No.: 1377615-44-5
Purity:  99.18%
Target:  

mGluR

Research Areas:  

Neurological Disease

LY3020371 hydrochloride is a potent, selective metabotropic glutamate 2/3 receptor (mGlu2/3) antagonist with Ki of 5.3 and 2.5 nM, potently blocks cAMP formation with IC50 of 16.2 nM . LY3020371 hydrochloride exerts an antidepressant-like signature in vivo .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-146052
CAS No.: 2691054-63-2
Purity:  99.23%
Target:  

Atg8/LC3 Autophagy

Research Areas:  

Cancer

Autophagy inducer 3 has autophagy induced activity. Autophagy inducer 3 possesses robust autophagic cell death in diverse cancer cells sparing normal counterpart. Autophagy inducer 3 induces lethal autophagy by formation of characteristic autophagic vacuoles, LC3 puncta formation, upregulation of signature autophagy markers like Beclin and Atg family proteins .
loading...
    loading...
Cat. No.: HY-137438
CAS No.: 1858206-58-2
Purity:  99.75%
Synonyms: TG-1701
Target:  

Btk

Research Areas:  

Cancer

Edralbrutinib (TG-1701) is a highly selective, orally available irreversible BTK inhibitor, with an EC50 of 6.70 nM and a Kd of 3 nM against human BTK. Edralbrutinib inhibits downstream signaling of the B cell receptor, induces dephosphorylation of Ikaros Ser442/445, promotes nuclear exclusion of Ikaros, attenuates Ikaros gene signatures, and exerts anti-tumor activity. Edralbrutinib can be used in research related to B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-15241
CAS No.: 902156-99-4
Purity:  98.81%
Synonyms: LCQ-195; AT9311
Target:  

CDK

Research Areas:  

Cancer

NVP-LCQ195 (LCQ-195) is an inhibitor of CDK1/2/3/5/9. NVP-LCQ195 induces cell cycle arrest and eventual apoptotic cell death of multiple myeloma (MM) cells. NVP-LCQ195 triggers decreased amplitude of transcriptional signatures related to oncogenesis, drug resistance and stem cell renewal in MM cell lines .
loading...
    loading...
Cat. No.: HY-139621
CAS No.: 2916559-62-9
Research Areas:  

Cancer

Colibactin 742 is a covalently binding DNA-damaging agent targeting DNA, with an IC50 of 5.2 μM against human cervical cancer cells (HeLa). Colibactin 742 covalently binds to DNA, forming interstrand crosslinks (ICLs), activating the Fanconi anemia DNA repair pathway, inducing γH2AX and FANCD2 foci formation and cell cycle arrest, while exacerbating mismatch repair deficiency (MMRd)-related mutations. Colibactin 742 can mimic the genotoxicity of natural Colibactin while avoiding its instability, and is mainly used in colorectal cancer (CRC) related research, including microbial tumorigenesis mechanisms, DNA damage repair pathways, and mutation signature analysis .
loading...
    loading...
Cat. No.: HY-P3146A
Target:  

Drug Metabolite

Research Areas:  

Cancer

FTISADTSK acetate is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM) .
loading...
    loading...
Cat. No.: HY-P3146S
Research Areas:  

Cancer

FTISADTSK- 13C6, 15N2 TFA is 13C- and 15N-labeled FTISADTSK (HY-P3146). FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM) .
loading...
    loading...
Cat. No.: HY-P3147A
Target:  

Drug Metabolite

Research Areas:  

Others

IYPTNGYTR acetate, a deamidation-sensitive signature peptide, is a deamidation product of Trastuzumab. IYPTNGYTR acetate can be used to monitor in vivo Trastuzumab metabolism .
loading...
    loading...
Cat. No.: HY-165854
CAS No.: 60485-39-4
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

12-Oxo-9 (Z)-dodecenoic acid is an endogenous metabolite produced by fatty acid metabolism, and it is associated with the predictive biomarker signature for improved endothelial injury in type 2 diabetes. 12-Oxo-9 (Z)-dodecenoic acid can be used in the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P3146
CAS No.: 1431957-73-1
Target:  

Drug Metabolite

Research Areas:  

Cancer

FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM) .
loading...
    loading...
Cat. No.: HY-P5168S
Research Areas:  

Infection

GPSVFPLAPSSK- 13C6, 15N2 is the 13C- and 15N-labeled GPSVFPLAPSSK. GPSVFPLAPSSK is an IgG1 signature peptide of anti-SARS-CoV-2 antibodies. GPSVFPLAPSSK can be used for the quantification of the specific isolation of anti-SARS-CoV-2 antibodies .
loading...
    loading...
Cat. No.: HY-P3147
CAS No.: 1431957-72-0
Target:  

Drug Metabolite

Research Areas:  

Others

IYPTNGYTR, a deamidation-sensitive signature peptide, is a deamidation product of Trastuzumab. IYPTNGYTR can be used to monitor in vivo Trastuzumab metabolism .
loading...
    loading...
Cat. No.: HY-P5168AS
Research Areas:  

Infection

GPSVFPLAPSSK- 13C6, 15N2 TFA is the 13C- and 15N-labeled GPSVFPLAPSSK. GPSVFPLAPSSK is an IgG1 signature peptide of anti-SARS-CoV-2 antibodies. GPSVFPLAPSSK can be used for the quantification of the specific isolation of anti-SARS-CoV-2 antibodies .
loading...
    loading...
Cat. No.: HY-162910
HDAC-IN-79 (compound 4) is an orally active dual xanthine oxidase-HDAC inhibitor (Xanthine oxidase: IC50=6.6 nM; HDAC1: IC50=134 nM; HDAC2: IC50=284 nM; HDAC3: IC50=173 nM; HDAC6: IC50=1.32 nM;), with significant in vivo anti-hyperuricemia and anti-tumor activities. HDAC-IN-79 is the most potent cell growth inhibitor (IC50=0.706 μM) of leukemia HL60 cells, induces apoptosis and autophagy, and can regulate the expression levels of signature biomarkers associated with intracellular HDAC inhibition .
loading...
    loading...
Cat. No.: HY-126855S
CAS No.: 1332881-66-9
Synonyms: 7-Sulfocholic acid-d4
Cholic acid 7-sulfate-d4 (7-Sulfocholic acid-d4) is the deuterium labeled Cholic acid 7-sulfate (HY-126855). Cholic acid 7-sulfate is a selective agonist targeting TGR5 (EC50=0.17 μM) and a ligand for MHC class I-related protein (MR1). As a gut-restricted TGR5 agonist, cholic acid 7-sulfate binds to TGR5 on enteroendocrine L cells, induces GLP-1 secretion, and improves glucose tolerance in a TGR5-dependent manner. Cholic acid 7-sulfate also acts as an endogenous ligand for MR1, promoting the survival of mucosal-associated invariant T cells MAIT and the expression of homeostatic gene signatures, affecting MAIT cell development and function. Cholic acid 7-sulfate is mainly used in the research of diabetes and MAIT cell-related immune regulation .
loading...
    loading...
Cat. No.: HY-15313B
CAS No.: 2070014-96-7
Purity:  ≥98.0%
Target:  

Histone Demethylase

Research Areas:  

Metabolic Disease Cancer

CBB1007 hydrochloride is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 µM for human LSD1. CBB1007 hydrochloride significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 hydrochloride shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 hydrochloride is studied in  non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma .
loading...
    loading...
Cat. No.: HY-P11556
CAS No.: 193413-91-1
Research Areas:  

Others

LR-13 is a signature peptide identified from the egg white allergen ovalbumin (OVA). LR-13 can be used as a marker peptide for the detection of OVA allergens using UHPLC-MS/MS .
loading...
    loading...